1. Home
  2. XPON vs RDHL Comparison

XPON vs RDHL Comparison

Compare XPON & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expion360 Inc.

XPON

Expion360 Inc.

N/A

Current Price

$4.44

Market Cap

3.3M

Sector

Technology

ML Signal

N/A

RDHL

Redhill Biopharma Ltd.

N/A

Current Price

$0.51

Market Cap

3.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XPON
RDHL
Founded
2016
2009
Country
United States
Israel
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.3M
IPO Year
2022
2012

Fundamental Metrics

Financial Performance
Metric
XPON
RDHL
Price
$4.44
$0.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
88.2K
★ 2.6M
Earning Date
05-14-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 94.63
N/A
EPS
N/A
★ N/A
Revenue
★ $9,651,870.00
N/A
Revenue This Year
N/A
$381.91
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 71.59
N/A
52 Week Low
$0.26
$0.50
52 Week High
$11.79
$2.61

Technical Indicators

Market Signals
Indicator
XPON
RDHL
Relative Strength Index (RSI) 46.73 37.60
Support Level $4.56 N/A
Resistance Level $11.79 $1.07
Average True Range (ATR) 0.44 0.04
MACD -0.16 -0.01
Stochastic Oscillator 15.09 12.79

Price Performance

Historical Comparison
XPON
RDHL

About XPON Expion360 Inc.

Expion360 Inc focuses on the design, assembly, manufacturing, and sale of lithium iron phosphate (LiFePO4) batteries and related accessories for RV, marine, and industrial applications. Its high-performance battery solutions are designed for high energy density and a compact footprint, supported by engineering and intellectual property to enhance safety, quality, and performance. The company also engages in product design, development, and collaboration to strengthen customer relationships. It serves dealers, wholesalers, private-label customers, and OEMs, who distribute its products to end consumers. Its segment is Energy Storage (ES), providing lithium-based energy solutions backed by durable materials, optimized internal structures, and responsive customer service.

About RDHL Redhill Biopharma Ltd.

RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.

Share on Social Networks: